UK Innovation Zones

Compare places

Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.

Side by side

DimensionManchesterNorth WestLeeds & West YorkshireYorkshire and the HumberLondonGreater London
Sectors

Advanced Materials, Life Sciences, Digital Technologies, Creative Industries

Supporting: Artificial Intelligence, Advanced Manufacturing, Financial Technology, Engineering Biology

Life Sciences, Digital Technologies, Financial Technology

Supporting: Artificial Intelligence, Advanced Manufacturing, Creative Industries

Financial Technology, Artificial Intelligence, Creative Industries, Digital Technologies

Supporting: Life Sciences, Quantum Technologies, Engineering Biology, Defence & Security

Research
  • The University of Manchester
  • Manchester Metropolitan University
  • National Graphene Institute
  • Greater Manchester health innovation partnership
  • University of Leeds
  • Imperial College London
  • University College London
  • King's College London
  • Queen Mary University of London
  • The Alan Turing Institute
  • The Francis Crick Institute
Companies

Not recorded on the map.

  • Leeds health data and digital health cluster

Not recorded on the map.

Infrastructure
  • MediaCity
  • Advanced manufacturing Catapult capability, North West

National materials and graphene facilities, teaching hospitals and clinical research capability, and a major broadcast production estate.

Not recorded on the map.

Health data infrastructure, teaching hospitals and university research facilities.

  • Digital Catapult
  • Connected Places Catapult
  • Cell and Gene Therapy Catapult
  • Level39

University laboratories, teaching hospitals, data centre and compute capacity, and the densest transport network in the country.

Capital

A growing regional investor base and northern funds, with growth rounds usually led from London.

Financial services depth locally, but early-stage health technology capital remains limited.

  • London venture and growth capital ecosystem

Venture, growth and public market capital at a scale unmatched elsewhere in Europe, plus corporate venture arms and international investors with UK offices.

Government programmes

No place-based designation recorded.

No place-based designation recorded.

No place-based designation recorded.

What existsAdvanced materials research including graphene and 2D materials, a large health innovation base built on hospitals and universities, a substantial digital and cyber economy, and the biggest broadcast and creative cluster outside London.National health data organisations, medical technology, a large financial and professional services base and a research university with data and materials strength.Four research-intensive universities, the deepest venture and growth capital pool in Europe, financial regulators, the largest concentration of applied AI companies in the UK and a global-scale creative production economy — all within one travel-to-work area.
What's missing · UKIZ interpretationThe step from materials discovery to volume production, and a growth capital base proportionate to the research output. Health data at population scale is under-used by industry.A clear route for companies to work with health data at scale, and clinical adoption pathways that move faster than pilot projects.Circulation. Capital, talent and corporate demand concentrate in London rather than flowing outward, so capability elsewhere in Britain competes for attention with opportunities on the investor's doorstep. Cost also pushes production and scale-up activity out without a route back in.
What could connect · UKIZ interpretationMaterials research connected to Sheffield and Midlands manufacturing, and health innovation connected to Leeds health data capability — a corridor rather than three separate cities.Leeds health data capability connected to Manchester clinical research and to medical technology manufacturing, giving companies discovery, evidence and production in one region.London as the demand and capital node of a national network: investors, corporate buyers and regulators deliberately connected to complementary manufacturing, materials and energy capability in the North, Midlands, Scotland and Wales.
UKIZ relevanceManchester has scale in four different economies that rarely commission from each other. The proposed zone concentrates on connecting health, materials, digital and creative capability around shared missions.Health data at population scale is a national asset. The proposed Manchester mission and Leeds capability are complementary rather than competing.London's problem is not capability, it is direction of travel: capital and talent gravitate here rather than circulating. The proposed London zone focuses on using that density to fund and buy from capability elsewhere in Britain.
Last verified15 August 202615 August 202615 August 2026

Proposed by UKIZ · not a government designation